Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epidemiology and clinical presentation.

S C Textor1

  • 1Division of Hypertension, Mayo Clinic, Rochester, MN 55905, USA.

Seminars in Nephrology
|October 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary mitochondrial DNA copy number identifies renal mitochondrial injury in renovascular hypertensive patients undergoing renal revascularization: A Pilot Study.

Acta physiologica (Oxford, England)·2019
Same author

Editor's Choice - Comparison of Renal Outcomes in Patients Treated by Zenith<sup>®</sup> Fenestrated and Zenith<sup>®</sup> Abdominal Aortic Aneurysm Stent grafts in US Prospective Pivotal Trials.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2017
Same author

Renovascular hypertension 2014: what have we learned from CORAL?

Journal of human hypertension·2014
Same author

The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Glomerular volume and renal histology in obese and non-obese living kidney donors.

Kidney international·2006
Same author

Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Renovascular disease, primarily atherosclerotic renal artery stenosis, is rising in older adults. Early detection and intervention are crucial to prevent hypertension, cardiovascular events, and kidney failure.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Vascular Surgery

Background:

  • Renovascular disease prevalence is increasing, especially in elderly patients with atherosclerosis.
  • Clinical presentations are evolving due to medical advancements and comorbidities.
  • Atherosclerotic renal artery stenosis is the most common cause of renovascular hypertension, surpassing fibromuscular dysplasia.

Purpose of the Study:

  • To highlight the changing landscape of renovascular disease.
  • To emphasize the spectrum of clinical manifestations and potential adverse outcomes.
  • To guide clinicians on patient selection for renal revascularization.

Main Methods:

  • Review of clinical manifestations and diagnostic considerations for renovascular disease.

Related Experiment Videos

  • Analysis of the impact of medical therapies, including renin-angiotensin system blockers.
  • Evaluation of risk-benefit assessment for renal revascularization procedures.

    • Main Results:

    • Renovascular hypertension can range from asymptomatic to severe, leading to cardiovascular complications and renal failure.
    • Widespread use of renin-angiotensin system inhibitors may mask renovascular hypertension, delaying diagnosis.
    • Disease progression can lead to renal artery occlusion and loss of kidney function.

    Conclusions:

    • Clinicians must maintain a high index of suspicion for renovascular disease progression.
    • Careful patient selection for renal revascularization is essential, balancing procedural risks with potential benefits for blood pressure and renal function.
    • Prompt diagnosis and management are key to improving outcomes in patients with renovascular disease.